Vigabatrin, a drug used primarily for the treatment of epilepsy and infantile spasms, has established itself as a significant player in the pharmaceutical market. Known for its effectiveness in managing refractory complex partial seizures, it operates by inhibiting the enzyme GABA transaminase, leading to an increase in the levels of gamma-aminobutyric acid (GABA) in the brain. This increase...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian